The usual things for fund are deals in the range of 50 - 100 millions dollars. The high activity for fund was in 2010. The fund is constantly included in less than 2 deals per year.
The typical case for the fund is to invest in rounds with more than 10 participants. Despite the ARCH Healthcare Fund, startups are often financed by Vertex Ventures HC, Vertex Ventures, New Enterprise Associates. The meaningful sponsors for the fund in investment in the same round are Windham Venture Partners, Vertex Ventures HC, Vertex Ventures. In the next rounds fund is usually obtained by Kohlberg Kravis Roberts.
The fund has no exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Life Science, Medical Device. Among the most popular portfolio startups of the fund, we may highlight Earlens Corporation, Arbor Pharmaceuticals.
| Fund Name | Location |
| Beyond Black | Berlin, Berlin, Germany |
| CG Health Ventures | Barcelona, Catalonia, Spain |
| Chuanggu Capital | Anhui, China, Hefei |
| Citizens Bank | Providence, Rhode Island, United States |
| Cypress Point Partners | Houston, Texas, United States |
| Deerfield Management | New York, New York, United States |
| Devenish Nutrition | Fairmont, Minnesota, United States |
| Hengqin Xiaozhong Youxuan Guquan Touzi | China, Guangdong, Zhuhai |
| HP Ventures Group | Chicago, Illinois, United States |
| Inter Invest Capital | France, Ile-de-France, Paris |
| International Real Returns | - |
| MCube8 | - |
| Moffu Labs | - |
| NIH Surgery | - |
| Print Marketing | - |
| Shanghai SIIC Fund Management | China, Shanghai |
| The Arena Capital | China, Shanghai |
| Tugboat | - |
| World Gold Council | England, London, United Kingdom |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Arbor Pharmaceuticals | $34M | 11 Nov 2010 | Atlanta, Georgia, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Arbor Pharmaceuticals | $34M | 11 Nov 2010 | Atlanta, Georgia, United States |
